Patents by Inventor M. Elizabeth Bush

M. Elizabeth Bush has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8690868
    Abstract: A modular biopsy, ablation and track coagulation needle apparatus is disclosed that allows the biopsy needle to be inserted into the delivery needle and removed when not needed, and that allows an inner ablation needle to be introduced and coaxially engaged with the delivery needle to more effectively biopsy a tumor, ablate it and coagulate the track through ablation while reducing blood loss and track seeding. The ablation needle and biopsy needle are adapted to in situ assembly with the delivery needle. In a preferred embodiment, the ablation needle, when engaged with the delivery needle forms a coaxial connector adapted to electrically couple to an ablating source. Methods for biopsying and ablating tumors using the device and coagulating the track upon device removal are also provided.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: April 8, 2014
    Assignee: Covidien LP
    Inventors: Jack W. Moorman, M. Elizabeth Bush
  • Patent number: 7807285
    Abstract: An energy storage device, such as an electrical storage battery, having a unique terminal structure and sealing arrangement. The battery generally includes a case in which an electrode assembly is disposed, and a cover provided with a fill hole and fill plug, and a terminal structure that forms a battery terminal. Both the positive and negative electrode tabs are compressed by a fastener that seals the battery and forms a battery terminal. The battery case can be positive, negative, or neutral.
    Type: Grant
    Filed: April 7, 2004
    Date of Patent: October 5, 2010
    Assignee: Quallion LLC
    Inventors: Paul Berg, Alex Z. Pàl, Jose A. Ulloa, Michael Escobar, M. Elizabeth Bush
  • Patent number: 7503943
    Abstract: Disclosed is an improved type of fluorinated carbon (CFx) for use in electrical storage devices such as batteries and capacitors. The CFx is coated with a conductive material such as gold or carbon using vapor deposition. The resulting material exhibits better conductivity with concomitant lower impedance, higher electrical stability, and improved potential throughout the useful life of the device, as compared to uncoated CFx. The improved conductivity reduces the amount of nonactive material (e.g., carbon black) that needs to be added, thus improving the volumetric energy density. In addition, cells made with the subject CFx exhibit more constant voltages and higher overall voltage (2.0 volts with a lithium metal anode) throughout their useful life. Chemical or physical vapor deposition techniques to deposit a variety of metals or carbon may be used to create the improved CFx. The coated CFx may be used in primary or secondary batteries, as well as capacitors and hybrid devices.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: March 17, 2009
    Assignee: Quallion LLC
    Inventors: Hisashi Tsukamoto, Kaname Takeya, Hiroyuki Yumoto, M. Elizabeth Bush
  • Patent number: 7341802
    Abstract: A feedthrough is insulated and hermetically sealed by brazing a ceramic disk to a case cover and by brazing the top surface of the ceramic disk to the bottom surface of a feedthrough pinhead. Using this technique instead of forming a compression seal, the surface area for bonding is increased, increasing bond strength. The ceramic disk electrically insulates the feedthrough pin from the cover, and provides a large surface area for mechanically sealing the cell with the braze. Considering the small size of many cells, this increased surface area is important for getting a good seal and increasing bond strength. This design also creates a longer fluid path, providing greater hermeticity. Furthermore, a greater range of component material combinations is available because CTE compatibility limitations of the feedthrough pin, cover, and insulator are minimized. This feedthrough is applicable to broad array of applications and numerous material combinations.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: March 11, 2008
    Assignee: Quallion LLC
    Inventors: Naoki Ota, Hiroshi Nakahara, David L. DeMuth, M. Elizabeth Bush
  • Patent number: 7160292
    Abstract: A modular biopsy, ablation and track coagulation needle apparatus is disclosed that allows the biopsy needle to be inserted into the delivery needle and removed when not needed, and that allows an inner ablation needle to be introduced and coaxially engaged with the delivery needle to more effectively biopsy a tumor, ablate it and coagulate the track through ablation while reducing blood loss and track seeding. The ablation needle and biopsy needle are adapted to in situ assembly with the delivery needle. In a preferred embodiment, the ablation needle, when engaged with the delivery needle forms a coaxial connector adapted to electrically couple to an ablating source. Methods for biopsying and ablating tumors using the device and coagulating the track upon device removal are also provided.
    Type: Grant
    Filed: May 1, 2003
    Date of Patent: January 9, 2007
    Assignee: Vivant Medical, Inc.
    Inventors: Jack W. Moorman, M. Elizabeth Bush
  • Patent number: 7052802
    Abstract: Disclosed is an improved type of fluorinated carbon (CFx) for use in electrical storage devices such as batteries and capacitors. The CFx is coated with a conductive material such as gold or carbon using vapor deposition. The resulting material exhibits better conductivity with concomitant lower impedance, higher electrical stability, and improved potential throughout the useful life of the device, as compared to uncoated CFx. The improved conductivity reduces the amount of nonactive material (e.g., carbon black) that needs to be added, thus improving the volumetric energy density. In addition, cells made with the subject CFx exhibit more constant voltages and higher overall voltage (2.0 volts with a lithium metal anode) throughout their useful life. Chemical or physical vapor deposition techniques to deposit a variety of metals or carbon may be used to create the improved CFx. The coated CFx may be used in primary or secondary batteries, as well as capacitors and hybrid devices.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: May 30, 2006
    Assignee: Quallion LLC
    Inventors: Hisashi Tsukamoto, Kaname Takeya, Hiroyuki Yumoto, M. Elizabeth Bush
  • Patent number: 6722371
    Abstract: This invention is an improved tissue localizing device for fixedly yet removably marking a volume of tissue containing a suspect region for excision. This invention also encompasses methods for deployment of the localizing device and its excision along with the marked tissue volume. At least one locator element is deployed into tissue and assumes a predetermined curvilinear shape to define a tissue border containing a suspect tissue region along a path. The locator element path preferably encompasses the distalmost portion of the tissue volume without penetrating that volume. Multiple locator elements may be deployed to further define the tissue volume along additional paths defining the tissue volume border that do not penetrate the volume. Other localization wire embodiments of the invention are disclosed in which the tissue volume may be penetrated by a portion of the device.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: April 20, 2004
    Inventors: Thomas J. Fogarty, David B. Willis, Thomas A. Howell, George D. Hermann, Peter M. Wilson, M. Elizabeth Bush
  • Publication number: 20040072075
    Abstract: Disclosed is an improved type of fluorinated carbon (CFx) for use in electrical storage devices such as batteries and capacitors. The CFx is coated with a conductive material such as gold or carbon using vapor deposition. The resulting material exhibits better conductivity with concomitant lower impedance, higher electrical stability, and improved potential throughout the useful life of the device, as compared to uncoated CFx. The improved conductivity reduces the amount of nonactive material (e.g., carbon black) that needs to be added, thus improving the volumetric energy density. In addition, cells made with the subject CFx exhibit more constant voltages and higher overall voltage (2.0 volts with a lithium metal anode) throughout their useful life. Chemical or physical vapor deposition techniques to deposit a variety of metals or carbon may be used to create the improved CFx. The coated CFx may be used in primary or secondary batteries, as well as capacitors and hybrid devices.
    Type: Application
    Filed: October 15, 2002
    Publication date: April 15, 2004
    Applicant: Quallion LLC
    Inventors: Hisashi Tsukamoto, Kaname Takeya, Hiroyuki Yumoto, M. Elizabeth Bush
  • Patent number: 6652520
    Abstract: A modular biopsy, ablation and track coagulation needle apparatus is disclosed that allows the biopsy needle to be inserted into the delivery needle and removed when not needed, and that allows an inner ablation needle to be introduced and coaxially engaged with the delivery needle to more effectively biopsy a tumor, ablate it and coagulate the track through ablation while reducing blood loss and track seeding. The ablation needle and biopsy needle are adapted to in situ assembly with the delivery needle. In a preferred embodiment, the ablation needle, when engaged with the delivery needle forms a coaxial connector adapted to electrically couple to an ablating source. Methods for biopsying and ablating tumors using the device and coagulating the track upon device removal are also provided.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: November 25, 2003
    Assignee: Vivant Medical, Inc.
    Inventors: Jack W. Moorman, M. Elizabeth Bush
  • Publication number: 20030195500
    Abstract: A modular biopsy, ablation and track coagulation needle apparatus is disclosed that allows the biopsy needle to be inserted into the delivery needle and removed when not needed, and that allows an inner ablation needle to be introduced and coaxially engaged with the delivery needle to more effectively biopsy a tumor, ablate it and coagulate the track through ablation while reducing blood loss and track seeding. The ablation needle and biopsy needle are adapted to in situ assembly with the delivery needle. In a preferred embodiment, the ablation needle, when engaged with the delivery needle forms a coaxial connector adapted to electrically couple to an ablating source. Methods for biopsying and ablating tumors using the device and coagulating the track upon device removal are also provided.
    Type: Application
    Filed: May 1, 2003
    Publication date: October 16, 2003
    Inventors: Jack W. Moorman, M. Elizabeth Bush
  • Patent number: 6582426
    Abstract: A modular biopsy, ablation and track coagulation needle apparatus is disclosed that allows the biopsy needle to be inserted into the delivery needle and removed when not needed, and that allows an inner ablation needle to be introduced and coaxially engaged with the delivery needle to more effectively biopsy a tumor, ablate it and coagulate the track through ablation while reducing blood loss and track seeding. The ablation needle and biopsy needle are adapted to in situ assembly with the delivery needle. In a preferred embodiment, the ablation needle, when engaged with the delivery needle forms a coaxial connector adapted to electrically couple to an ablating source. Methods for biopsying and ablating tumors using the device and coagulating the track upon device removal are also provided.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: June 24, 2003
    Assignee: Vivant Medical, Inc.
    Inventors: Jack W. Moorman, M. Elizabeth Bush
  • Patent number: 6405733
    Abstract: This invention is an improved tissue localizing device for fixedly yet removably marking a volume of tissue containing a suspect region for excision without penetrating that volume. This invention also encompasses methods for deployment of the localizing device and its excision along with the marked tissue volume. At least one locator element is deployed into tissue and assumes a predetermined curvilinear shape to define a tissue border containing a suspect tissue region along a path. The locator element path preferably encompasses the distalmost portion of the tissue volume without penetrating that volume. Multiple locator elements may be deployed to further define the tissue volume along additional paths defining the tissue volume border that do not penetrate the volume. Polar and tangential deployment configurations as well as a locator element that may be cold-formed by a die in the distal portion of the deployment tube into a permanent arcuate shape is also disclosed.
    Type: Grant
    Filed: July 11, 2000
    Date of Patent: June 18, 2002
    Inventors: Thomas J. Fogarty, David B. Willis, Thomas A. Howell, George D. Hermann, Peter M. Wilson, M. Elizabeth Bush
  • Publication number: 20020058932
    Abstract: A modular biopsy, ablation and track coagulation needle apparatus is disclosed that allows the biopsy needle to be inserted into the delivery needle and removed when not needed, and that allows an inner ablation needle to be introduced and coaxially engaged with the delivery needle to more effectively biopsy a tumor, ablate it and coagulate the track through ablation while reducing blood loss and track seeding. The ablation needle and biopsy needle are adapted to in situ assembly with the delivery needle. In a preferred embodiment, the ablation needle, when engaged with the delivery needle forms a coaxial connector adapted to electrically couple to an ablating source. Methods for biopsying and ablating tumors using the device and coagulating the track upon device removal are also provided.
    Type: Application
    Filed: October 18, 2001
    Publication date: May 16, 2002
    Applicant: Vivant Medical, Inc.
    Inventors: Jack W. Moorman, M. Elizabeth Bush
  • Patent number: 6355033
    Abstract: A modular biopsy, ablation and track coagulation needle apparatus is disclosed that allows the biopsy needle to be inserted into the delivery needle and removed when not needed, and that allows an inner ablation needle to be introduced and coaxially engaged with the delivery needle to more effectively biopsy a tumor, ablate it and coagulate the track through ablation while reducing blood loss and track seeding. The ablation needle and biopsy needle are adapted to in situ assembly with the delivery needle. In a preferred embodiment, the ablation needle, when engaged with the delivery needle forms a coaxial connector adapted to electrically couple to an ablating source. Methods for biopsying and ablating tumors using the device and coagulating the track upon device removal are also provided.
    Type: Grant
    Filed: July 16, 1999
    Date of Patent: March 12, 2002
    Assignee: Vivant Medical
    Inventors: Jack W. Moorman, M. Elizabeth Bush
  • Patent number: 6325796
    Abstract: A microwave ablation assembly and method including a relatively thin, elongated probe (21) having a proximal access end (22) and an opposite distal penetration end (23) adapted to penetrate into bio-tissue (25). The probe (21) defines an insert passage (26) extending therethrough from the access end (22) to the penetration end (23) thereof. An ablation catheter includes a coaxial transmission line (28) with an antenna device (30) coupled to a distal end of the transmission line (28) for generating an electric field sufficiently strong to cause tissue ablation. The coaxial transmission line (28) includes an inner conductor (31) and an outer conductor (32) separated by a dielectric material medium (33). A proximal end of the transmission line (28) is coupled to a microwave energy source.
    Type: Grant
    Filed: May 4, 1999
    Date of Patent: December 4, 2001
    Assignee: AFx, Inc.
    Inventors: Dany Berube, M. Elizabeth Bush
  • Publication number: 20010039416
    Abstract: A modular biopsy, ablation and track coagulation needle apparatus is disclosed that allows the biopsy needle to be inserted into the delivery needle and removed when not needed, and that allows an inner ablation needle to be introduced and coaxially engaged with the delivery needle to more effectively biopsy a tumor, ablate it and coagulate the track through ablation while reducing blood loss and track seeding. The ablation needle and biopsy needle are adapted to in situ assembly with the delivery needle. In a preferred embodiment, the ablation needle, when engaged with the delivery needle forms a coaxial connector adapted to electrically couple to an ablating source. Methods for biopsying and ablating tumors using the device and coagulating the track upon device removal are also provided.
    Type: Application
    Filed: April 6, 2001
    Publication date: November 8, 2001
    Applicant: Vivant Medical
    Inventors: Jack W. Moorman, M. Elizabeth Bush
  • Patent number: 6306132
    Abstract: A modular biopsy, ablation and track coagulation needle apparatus is disclosed that allows the biopsy needle to be inserted into the delivery needle and removed when not needed, and that allows an inner ablation needle to be introduced and coaxially engaged with the delivery needle to more effectively biopsy a tumor, ablate it and coagulate the track through ablation while reducing blood loss and track seeding. The ablation needle and biopsy needle are adapted to in situ assembly with the delivery needle. In a preferred embodiment, the ablation needle, when engaged with the delivery needle forms a coaxial connector adapted to electrically couple to an ablating source. Methods for biopsying and ablating tumors using the device and coagulating the track upon device removal are also provided.
    Type: Grant
    Filed: June 17, 1999
    Date of Patent: October 23, 2001
    Assignee: Vivant Medical
    Inventors: Jack W. Moorman, M. Elizabeth Bush
  • Patent number: 5837007
    Abstract: Intracardiac lead for compliant fixation of a distal end of the lead to cardiac tissue. A fixation helix is disposed at the distal end of the lead. The fixation helix has a first end rigidly attached to the compliant fixation device and a second end that is sharpened to facilitate insertion of the fixation helix into cardiac tissue. The fixation helix can be designed to provide for either electrically active or inactive fixation. Once the lead is implanted in the cardiac tissue, the compliant fixation device, connecting the lead with the fixation helix, reduces the amount of lead movement that is transferred to the patient's tissue at the site of implantation of the fixation helix and reduces those forces from lead movement that could cause dislodgment of the fixation helix.
    Type: Grant
    Filed: March 26, 1997
    Date of Patent: November 17, 1998
    Assignee: Pacesetter, Inc.
    Inventors: Peter A. Altman, M. Elizabeth Bush, Dean F. Carson
  • Patent number: 5755762
    Abstract: A continuous sheath of open-celled porous plastic, preferably ePTFE, is used on the outside of an implantable lead, extending along the lead body and the electrodes, in such a way that the lead is isodiametric along its length, and is very strong in tension as is required for lead removal. Because the plastic is open-celled, when the pores are filled with saline, the lead can deliver defibrillation energy through the pores in the plastic. Pore size is chosen to discourage tissue ingrowth while allowing for defibrillation energy delivery through it.
    Type: Grant
    Filed: June 14, 1996
    Date of Patent: May 26, 1998
    Assignee: Pacesetter, Inc.
    Inventor: M. Elizabeth Bush
  • Patent number: 5749901
    Abstract: A method for defibrillating a patient's heart with an implantable defibrillator having defibrillation synchronized to the fibrillation waveform is disclosed. The defibrillator is used to detect fibrillation in a patient's heart, monitor at least two far-field fibrillation voltages across at least three spaced-apart electrodes while the high voltage capacitors are charging, then deliver a high energy shock during a period of ventricular fibrillation when the absolute values of the peak and trough voltages exceed a threshold based on a desired percentage greater than a running average of the absolute values of the peaks and troughs of the fibrillation voltages monitored during and after capacitor charging. The shock is then delivered synchronous with the next significant cardiac complex. The defibrillator also includes a safety timer so that if the threshold is not reached within a specified safe time limit, the high energy shock will be delivered without further delay.
    Type: Grant
    Filed: May 7, 1996
    Date of Patent: May 12, 1998
    Assignee: Pacesetter, Inc.
    Inventors: M. Elizabeth Bush, Eric S. Fain